TP53 and ovarian carcinoma: Type I ovarian carcinomas generally develop from ovarian benign neoplasms, which in turn progress towards borderline and invasive carcinomas; they display a less aggressive behavior, with low metastatic spread at the time of diagnosis, stable genome, and generally no TP53 mutations, although several somatic mutations have been described [46].